SOLVONIS THERAPEUTICS PLC earnings
Annual earnings per share (GBP per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2025 | 2025-12-31 | — | £-0.00 | 2026-06-19T14:27:43Z |
| 2024 | 2024-12-31 | — | £-0.00 | 2026-06-19T14:27:43Z |
Revenue & profit (GBP)
| Concept | 2025 | 2024 |
|---|---|---|
| Revenue | £0 | £0 |
| Profit for the year | -£5.7M | -£1.6M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in SOLVONIS THERAPEUTICS PLC's ESEF annual reports (source:
filings.xbrl.org).
Figures are in GBP, as reported. Not investment advice.